Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3547-3553

  Durali, Deniz ^a   Morvan, Jacques ^c   Letourneur, Franck ^a   Schmitt, Doris ^b   Guegan, Nelly ^a   Dalod, Marc ^a   Saragosti, Sentob ^a   Sicard, Didier ^a   Levy, Jean Paul ^a   Gomard, Elisabeth ^a  

^a Université Paris Descartes   (France)

^b TRANSGENE S A   (France)

^c INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GAG PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS TYPING;

EID: 0031980208     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3547-3553.1998     Document Type: Article

References (43)

1. Ariyoshi, K., F. Cham, N. Berry, S. Jaffar, S. Sabally, T. Corrah, and H. Whittle. 1995. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 9:555-559.
2. Bolognesi, D. 1989. HIV antibodies and vaccine design. AIDS 3:S111-S119.
3. Brander, C., and B. D. Walker. 1995. The HLA-class I-restricted CTL response in HIV-1 infection; identification of optimal epitopes. HIV Molecular Immunology Database, Los Alamos National Laboratory, Los Alamos, N.Mex. IV-1 to IV-8.
4. + cytotoxic T-cell clone. Immunol. Lett. 55:145-149.
5. Carmichael, A., X. Jin, and P. Sissons. 1996. Analysis of the human env cytotoxic T-lymphocyte (CTL) response in natural immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL. J. Virol. 70:8468-8476.
6. Cheynier, R., P. Langlade-Demoyen, M. R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1993. Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur. J. Immunol. 22:2211-2217.
7. Culmann-Penciolelli, B., S. Lamhamedi-Cherradi, I. Couillin, N. Guegan, J.-P. Levy, J.-G. Guillet, and E. Gomard. 1994. Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J. Virol. 68:7336-7343.
8. Delwart, E. W., E. G. Shpaet, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1992. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
9. Dimmock, N. J. 1993. Neutralization of animal viruses. Curr. Top. Microbiol. Immunol. 183:1-149.
10. Ferrari, G., W. Humphrey, M. J. McElrath, J.-L. Excler, A.-M. Duliège, M. L. Clements, L. C. Corey, D. P. Bolognesi, and K. J. Weinhold. 1997. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA 94:1396-1401.
11. Gao, F., D. L. Robertson, S. G. Morrison, H. Hui, S. Craig, J. Decker, P. N. Fultz, M. Girard, G. M. Shaw, B. H. Hahn, and P. M. Sharp. 1996. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J. Virol. 70: 7013-7029.
12. Gotch, F., S. N. McAdam, C. E. L. Allsopp, A. Gallimore, J. Elvin, M.-P. Kiény, A. V. S. Andrew, A. J. McMichael, and H. C. Whittle. 1993. Cytotoxic T cells in HIV-2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 151:3361-3369.
13. Goulder, P., C. Conlon, K. McIntyre, and A. McMichael. 1996. Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag. AIDS 10:1442-1443.
14. Goulder, P. J. R., A. Edwards, R. E. Phillips, and A. J. McMichael. 1997. Identification of a novel HLA-B3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides. AIDS 11:930-931.
15. Haas, G., U. Plikat, P. Debré, M. Lucchiari, C. Katlama, Y. Dudoit, O. Bonduelle, M. Bauer, H.-G. Ihlenfeldt, G. Jung, B. Maier, A. Meyermans, and B. Autran. 1996. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 157:4212-4221.
16. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, S. I. Staprans, M. B. Feinberg, Y. Cao, D. H. Ho, T. Yilma, A. M. Caliendo, R. P. Johnson, S. P. Buchbinder, and B. D. Walker. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses 12:585-592.
17. Harrer, T., E. Harrer, S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johson, T. Elbeik, M. B. Feinberg, S. P. Buchbinder, and B. D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156: 2616-2623.
18. Klenerman, P., G. Luzzi, K. McIntyre, R. Phillips, and A. McMichael. 1996. Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). AIDS 10:348-349.
19. Koenig, S., T. R. Fuerst, L. V. Wood, R. M. Woods, J. A. Suzich, G. Jones, V. de la Crux, R. Davey, S. Venkatesan, B. Moss, W. Biddison, and A. Fauci. 1990. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J. Immunol. 145:127-135.
20. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, B. Guy, M.-P. Kiény, F. Dreyfus, et al. 1992. Qualitative and quantitative analysis of human cytotoxic T lymphocyte responses to HIV-1 proteins. AIDS 6:1249-1258.
21. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, B. Guy, T. H. Ly, C. Goujard, J.-G. Guillet, and E. Gomard. 1995. Different patterns of HIV-1 specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9: 421-426.
22. McMichael, A. J., and B. D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8:S155-S173.
23. Meyers, G., B. Korber, B. Hahn, et al. (ed.). 1995. Human retroviruses and AIDS 1995: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
24. Murphy, E., B. Korber, M. C. Geaoges-Courbot, B. You, A. Pinter, D. Cook, M.-P. Kiény, A. Georges, C. Mathiot, F. Barré-Sinoussi, et al. 1993. Diversity of V3 region sequences of human immunodeficiency virus type 1 from the Central African Republic. AIDS Res. Hum. Retroviruses 10:997-1006.
25. Nixon, D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484-487.
26. Nixon, D. F., S. Huet, J. Rothbard, M.-P. Kiény, M. Delchambre, C. Thiriart, C. R. Rizza, F. M. Gotch, and A. J. McMichael. 1990. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS 4:841-845.
27. Palker, T. J., M. L. Clarck, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of HIV with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85:1932-1936.
28. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
29. Rivière, Y., M. B. McChesnay, F. Porrot, et al. 1995. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 8:903-907.
30. Robertson, D. L., P. M. Sharp, F. E. McCutchan, and B. H. Hahn. 1995. Recombination in HIV-1. Nature (London) 374:124-126.
31. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
32. Safrit, J. T., and R. A. Koup. 1995. The immunology of primary HIV infections: which immune responses control HIV replication? Curr. Opin. Immunol. 7:456-461.
33. Sanders-Buell, E., M. O. Salminen, and F. E. McCutchan. 1995. Sequencing primers for HIV-1, human retroviruses and AIDS, vol. III, p. 15-21. Los Alamos National Laboratory, Los Alamos, N.Mex.
34. Saragosti, S. Unpublished data.
35. Scott, C. F., S. Silver, A. T. Profy, S. D. Putney, A. Langlois, K. Weinhold, and J. E. Robinson. 1990. Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type III-MN strain. Proc. Natl. Acad. Sci. USA 87:8597-8603.
36. Shiga, H., T. Shiado, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H.-G. Rammensse, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10:1075-1083.
37. Sipsas, N. V., S. A. Kalams, A. Trocha, S. He, W. A. Blattner, and B. D. Walker. 1997. Identification of type-specific T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 99:752-762.
38. Thompson, J. D., D. G. Higgind, and T. J. Gibson. 1994. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gag penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
39. Tomiyama, H., K. Miwa, H. Shiga, Y. I. Moore, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B3501 molecules that are associated with the accelerated progression of AIDS. J. Immunol. 158:5026-5034.
40. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
41. Venet, A., and B. D. Walker. 1993. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 7:S117-S126.
42. Wilson, C. C., S. A. Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I. C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S. P. Buchbinder, R. P. Johnson, and B. D. Walker. 1997. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA-A, -B, and -C molecules: effects of viral mutation on cytotoxic T-lymphocyte recognition. J. Virol. 71: 1256-1264.
43. Yang, O. O., S. A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B. D. Walker, and R. P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70: 5799-5806.